Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azilsartan medoxomil - Takeda

Next Previous
X
Search
Drug Profile

Azilsartan medoxomil - Takeda

Alternative Names: Azilsartan kamedoxomil; Azilsartan medoxomil potassium; CTL-0801; Edarbi; Ipreziv; TAK-491

Latest Information Update: 22 Feb 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Developer Arbor Pharmaceuticals; Takeda
  • Class Antihypertensives; Benzimidazoles; Esters; Ethers; Ketones; Oxadiazoles; Small molecules
  • Mechanism of Action Angiotensin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 22 Feb 2023 No development reported - Phase-III for Hypertension (In adolescents, In children) in South Africa, Poland, Hungary, Hungary, Puerto Rico, USA, Bulgaria, Ukraine, Turkey, Mexico, Italy, Colombia, Brazil and Argentina (PO)
  • 13 Sep 2021 Celltrion completes phase I drug-drug interaction study (In volunteers) in China (PO) (NCT05002244)
  • 23 Jul 2021 Celltrion initiates enrolment in a phase I drug-drug interaction study (In volunteers) in China (PO) (NCT05002244)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top